B2m-KO
品系全名
C57BL/6JSmo-B2mem3Smoc
目录号
NM-KO-18021
品系状态
活体
基因信息
基因名
B2M
品系描述
验证数据
Fig1 B2m基因敲除纯合子小鼠CD8+细胞毒性T细胞很少，CD4+T细胞代偿性增加。CD8+ T细胞相关免疫应答严重缺陷，可用于评估CD8+细胞和I类MHC的作用。
发表文献 1篇
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
